drugset / Trial / NCT07255209
A Study of IBI362 in Chinese Adolescents With Obesity or Overweight
RandomizedSequentialDouble-blindTreatment
Summary
The study is designed to assess the efficacy and safety of multiple doses of IBI362 in Chinese adolescent subjects with obesity or overweight. It plans to enroll 180 adolescents (aged ≥12 and \<18 years) who have failed to achieve a 5 kg weight reduction after at least 12 weeks of dietary and exercise intervention.
Timeline
- Start
- 2025-12-29
- Primary completion
- 2027-10-31
- Completion
- 2028-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mazdutide | Protein / enzyme biologic | — | — |
Indications
No indication recorded.